The Virtual Slides Dysplastic Naevus: Fact & Fiction course examines the scientific and clinical understanding of dysplastic nevi, focusing on their relevance to melanoma diagnosis and prognosis. The course is structured into one comprehensive unit, providing an in-depth review of dysplastic nevi from historical origins to modern perspectives.
The course navigates the historical evolution, diagnostic challenges, and clinical implications of dysplastic nevi.
Key Topics Covered:
- Defining Dysplastic Naevus
- Origins of the term "dysplastic nevus" and its evolution in dermatopathology.
- World Health Organization's histological criteria and current diagnostic approaches.
- Clarifying terminology: dysplasia, atypical moles, and architectural disorder.
- Clinical and Histological Features
- Differentiating between congenital, acquired, and dysplastic nevi.
- Identifying patterns in melanocytic lesions, including B-K mole syndrome and familial atypical multiple mole melanoma (FAMMM) syndrome.
- Histopathological analysis: grading atypia, interobserver variability, and challenges in classification.
- Controversies and Diagnostic Challenges
- Debating the role of dysplastic nevi as melanoma precursors.
- Examining the molecular and genetic differences between common, congenital, and dysplastic nevi.
- Addressing misconceptions in grading dysplasia and implications for clinical management.
- Risk Assessment and Patient Management
- Assessing melanoma risk based on nevus count, size, and genetic predisposition.
- Practical guidelines for monitoring and excising suspicious lesions.
- Understanding when to prioritise patient education over unnecessary surgical interventions.
- Interactive Learning with Virtual Slides
- Case studies demonstrating the evolution of nevi and early melanoma detection.
- Virtual slide analyses to reinforce diagnostic skills and decision-making.
This course is ideal for dermatologists, general practitioners, and other healthcare professionals seeking to deepen their understanding of dysplastic nevi and their relationship to melanoma.
All degree qualified medical practitioners.